These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 7525413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
    Nemchinov LG, Liang TJ, Rifaat MM, Mazyad HM, Hadidi A, Keith JM.
    Arch Virol; 2000 Mar; 145(12):2557-73. PubMed ID: 11205105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.
    Totrov M, Jiang X, Kong XP, Cohen S, Krachmarov C, Salomon A, Williams C, Seaman MS, Abagyan R, Cardozo T, Gorny MK, Wang S, Lu S, Pinter A, Zolla-Pazner S.
    Virology; 2010 Sep 30; 405(2):513-23. PubMed ID: 20663531
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    Jiang X, Totrov M, Li W, Sampson JM, Williams C, Lu H, Wu X, Lu S, Wang S, Zolla-Pazner S, Kong XP.
    J Virol; 2016 Dec 15; 90(24):11007-11019. PubMed ID: 27707920
    [Abstract] [Full Text] [Related]

  • 14. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R, Böltz T, Deml L, Modrow S, Wolf H.
    J Gen Virol; 1993 Jul 15; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S.
    Biotechnol Bioeng; 2005 Dec 30; 92(7):803-9. PubMed ID: 16142801
    [Abstract] [Full Text] [Related]

  • 17. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.
    Dertzbaugh MT, Peterson DL, Macrina FL.
    Infect Immun; 1990 Jan 30; 58(1):70-9. PubMed ID: 1688421
    [Abstract] [Full Text] [Related]

  • 18. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy.
    Law M, Cardoso RM, Wilson IA, Burton DR.
    J Virol; 2007 Apr 30; 81(8):4272-85. PubMed ID: 17267498
    [Abstract] [Full Text] [Related]

  • 19. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
    Lian T, Bui T, Ho RJ.
    Vaccine; 1999 Nov 12; 18(7-8):604-11. PubMed ID: 10547418
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
    Boberg A, Gaunitz S, Bråve A, Wahren B, Carlin N.
    Vaccine; 2008 Sep 19; 26(40):5079-82. PubMed ID: 18514370
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.